The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26367138 |
12 |
Design, Virtual Screening, and Synthesis of Antagonists ofaIIbß3 as Antiplatelet Agents. |
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine |
| 24900800 |
46 |
Small Macrocycles As Highly Active Integrin?2?1 Antagonists. |
Sanofi R & D |
| 17447751 |
1 |
Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function. |
University of Turku |
| 16919941 |
8 |
Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists. |
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine |
| 21852128 |
11 |
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor. |
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine |
| 19574045 |
44 |
Novel inhibitors of the alphavbeta3 integrin--lead identification strategy. |
Astrazeneca |
| 31999923 |
16 |
Insights into Protein-Ligand Interactions in Integrin Complexes: Advances in Structure Determinations. |
Pliant Therapeutics |
| 24568695 |
76 |
Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists. |
University of Bradford |
| 17915848 |
48 |
Small molecule inhibitors of integrin alpha2beta1. |
University of Pennsylvania |
Search and Browse
